Human TNF alpha Monoclonal Antibody
Produktgrößen
1 mg
£268,00
YR0014-1MG
5 mg
£746,00
YR0014-5MG
20 mg
£1442,00
YR0014-20MG
Über dieses Produkt
- SKU:
- YR0014
- Zusätzliche Namen:
- DIF|TNF|TNFA|TNFSF2|TNLG1F
- Anwendung:
- Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
- Klonalität:
- Monoclonal
- Weitere Details:
- Infliximab, a chimeric anti-TNF-A Alpha monoclonal antibody, is used to treat psoriasis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Infliximab interferes TNF-A Alpha from binding to its receptor in the cell.Mainly produced by activated macrophages (M1), Tumor necrosis factor (TNF, cachexin, cachectin, tumor necrosis factor alpha, TNFA Alpha) plays important roles in the regulation of autoimmune reaction.
- Formulierung:
- Purified from cell culture supernatant in an animal-free facility
- Immunogen:
- Human TNF alpha
- Isotyp:
- IgG1, kappa
- Molekulargewicht:
- 150 kDa
- Reinheit:
- >95%
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- ABclonal Technology
- Typ:
- Antibody: Biosimilar Antibody
- Datenblatt des Herstellers:YR0014